{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:39:32Z","timestamp":1793597972479,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Investigator Driven Grant","award":["ERP 2022-13079"],"award-info":[{"award-number":["ERP 2022-13079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00125-026-06780-9","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:10:33Z","timestamp":1782389433000},"page":"2421-2431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults \u226565 years with type 1 diabetes: a randomised, single-centre study"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-352X","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Matejko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Cyranka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Sudu\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Susu\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Kr\u0119\u017cel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliia","family":"Chernovol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Malecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"6780_CR1","doi-asserted-by":"publisher","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A et al (2021) The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 44(11):2589\u20132625. https:\/\/doi.org\/10.2337\/dci21-0043","DOI":"10.2337\/dci21-0043"},{"issue":"1","key":"6780_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","volume":"66","author":"JL Sherr","year":"2023","unstructured":"Sherr JL, Heinemann L, Fleming GA et al (2023) Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 66(1):3\u201322. https:\/\/doi.org\/10.1007\/s00125-022-05744-z","journal-title":"Diabetologia"},{"key":"6780_CR3","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2025) Standards of care in diabetes 2025. Diabetes Care 48(1 Suppl 1):266\u2013S282. https:\/\/doi.org\/10.2337\/dc25-S013","DOI":"10.2337\/dc25-S013"},{"issue":"12","key":"6780_CR4","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s13300-021-01160-5","volume":"12","author":"A Janez","year":"2021","unstructured":"Janez A, Battelino T, Klupa T et al (2021) Hybrid closed-loop systems for the treatment of type 1 diabetes: a collaborative, expert group position statement for clinical use in central and Eastern Europe. Diabetes Ther 12(12):3107\u20133135. https:\/\/doi.org\/10.1007\/s13300-021-01160-5","journal-title":"Diabetes Ther"},{"issue":"9","key":"6780_CR5","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1111\/dom.15718","volume":"26","author":"Q Yang","year":"2024","unstructured":"Yang Q, Zeng B, Hao J, Yang Q, Sun F (2024) Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: a meta-analysis. Diabetes Obes Metab 26(9):3753\u20133763. https:\/\/doi.org\/10.1111\/dom.15718","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"6780_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/dc23-0504","volume":"46","author":"B Zeng","year":"2023","unstructured":"Zeng B, Gao L, Yang Q, Jia H, Sun F (2023) Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care 46(12):2300\u20132307. https:\/\/doi.org\/10.2337\/dc23-0504","journal-title":"Diabetes Care"},{"key":"6780_CR7","doi-asserted-by":"publisher","first-page":"103190","DOI":"10.1016\/j.eclinm.2025.103190","volume":"82","author":"A Stahl-Pehe","year":"2025","unstructured":"Stahl-Pehe A, Shokri-Mashhadi N, Wirth M et al (2025) Efficacy of automated insulin delivery systems in people with type 1 diabetes: a systematic review and network meta-analysis of outpatient randomised controlled trials. EClinicalMedicine 82:103190. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103190","journal-title":"EClinicalMedicine"},{"issue":"8","key":"6780_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1089\/dia.2023.0059","volume":"25","author":"B Matejko","year":"2023","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B et al (2023) One-year follow-up of advanced hybrid closed-loop system in adults with type 1 diabetes previously naive to diabetes technology: the effect of switching to a calibration-free sensor. Diabetes Technol Ther 25(8):554\u2013558. https:\/\/doi.org\/10.1089\/dia.2023.0059","journal-title":"Diabetes Technol Ther"},{"key":"6780_CR9","doi-asserted-by":"publisher","first-page":"102852","DOI":"10.1016\/j.eclinm.2024.102852","volume":"76","author":"T Roos","year":"2024","unstructured":"Roos T, Hermanns N, Gro\u00df C, Kulzer B, Haak T, Ehrmann D (2024) Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes: a systematic review and meta-analysis. EClinicalMedicine. 76:102852. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102852","journal-title":"EClinicalMedicine."},{"key":"6780_CR10","doi-asserted-by":"publisher","first-page":"1210756","DOI":"10.3389\/fendo.2023.1210756","volume":"14","author":"K Cyranka","year":"2023","unstructured":"Cyranka K, Matejko B, Juza A et al (2023) Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type 1 diabetes previously na\u00efve to advanced diabetes technology. Front Endocrinol (Lausanne) 14:1210756. https:\/\/doi.org\/10.3389\/fendo.2023.1210756","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"S3","key":"6780_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/dia.2023.0433","volume":"26","author":"P Choudhary","year":"2024","unstructured":"Choudhary P, Arrieta A, van den Heuvel T, Casta\u00f1eda J, Smaniotto V, Cohen O (2024) Celebrating the data from 100,000 real-world users of the MiniMed\u2122 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence. Diabetes Technol Ther 26(S3):32\u201337. https:\/\/doi.org\/10.1089\/dia.2023.0433","journal-title":"Diabetes Technol Ther"},{"key":"6780_CR12","doi-asserted-by":"publisher","unstructured":"Dekker P, van den Heuvel T, Arrieta A et al (2024) Twelve-month real-world use of an advanced hybrid closed-loop system versus previous therapy in a Dutch center for specialized type 1 diabetes care. J Diabetes Sci Technol\u00a020(3). https:\/\/doi.org\/10.1177\/19322968241290259","DOI":"10.1177\/19322968241290259"},{"key":"6780_CR13","doi-asserted-by":"publisher","first-page":"111832","DOI":"10.1016\/j.diabres.2024.111832","volume":"216","author":"B Matejko","year":"2024","unstructured":"Matejko B, van den Heuvel T, Castaneda J et al (2024) Excellence in the management of advanced hybrid closed-loop systems: lessons from the polish cohort. Diabetes Res Clin Pract 216:111832. https:\/\/doi.org\/10.1016\/j.diabres.2024.111832","journal-title":"Diabetes Res Clin Pract"},{"key":"6780_CR14","doi-asserted-by":"publisher","first-page":"e078432","DOI":"10.1136\/bmj-2023-078432","volume":"385","author":"K Yang","year":"2024","unstructured":"Yang K, Yang X, Jin C et al (2024) Global burden of type 1 diabetes in adults aged 65 years and older, 1990\u20132019: population based study. BMJ 385:e078432. https:\/\/doi.org\/10.1136\/bmj-2023-078432","journal-title":"BMJ"},{"issue":"5","key":"6780_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-8587(24)00372-3","volume":"13","author":"M Munshi","year":"2025","unstructured":"Munshi M, Kahkoska AR, Neumiller JJ et al (2025) Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies. Lancet Diabetes Endocrinol 13(5):427\u2013437. https:\/\/doi.org\/10.1016\/S2213-8587(24)00372-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"6780_CR16","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","volume":"67","author":"G Maltese","year":"2024","unstructured":"Maltese G, McAuley SA, Trawley S, Sinclair AJ (2024) Ageing well with diabetes: the role of technology. Diabetologia 67(10):2085\u20132102. https:\/\/doi.org\/10.1007\/s00125-024-06240-2","journal-title":"Diabetologia"},{"issue":"1","key":"6780_CR17","doi-asserted-by":"publisher","first-page":"EVIDoa2400200","DOI":"10.1056\/EVIDoa2400200","volume":"4","author":"YC Kudva","year":"2025","unstructured":"Kudva YC, Henderson RJ, Kanapka LG et al (2025) Automated insulin delivery in older adults with type 1 diabetes. NEJM Evid 4(1):EVIDoa2400200. https:\/\/doi.org\/10.1056\/EVIDoa2400200","journal-title":"NEJM Evid"},{"issue":"Suppl 1","key":"6780_CR18","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1089\/dia.2024.2511","volume":"26","author":"S Sy","year":"2024","unstructured":"Sy S, Sinclair A, Munshi M, Kahkoska AR, Weinstock R, Cukierman-Yaffe T (2024) Use of technologies at the advanced age. Diabetes Technol Ther 26(Suppl 1):S172\u2013S186. https:\/\/doi.org\/10.1089\/dia.2024.2511","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"6780_CR19","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/dom.16227","volume":"27","author":"V Smaniotto","year":"2025","unstructured":"Smaniotto V, Heller S, O\u2019Neal D et al (2025) MiniMed 780G system performance in older users with type 1 diabetes: real-world evidence and the case for stricter glycaemic targets. Diabetes Obes Metab 27(4):2242\u20132250. https:\/\/doi.org\/10.1111\/dom.16227","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"6780_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1177\/15209156251376654","volume":"27","author":"A Chien","year":"2025","unstructured":"Chien A, Shin JJ, Liu M et al (2025) Real-world effectiveness of the MiniMed\u2122 780G advanced hybrid closed-loop system for people \u226565 years with type 1 or type 2 diabetes in the United States. Diabetes Technol Ther 27(12):989\u2013996. https:\/\/doi.org\/10.1177\/15209156251376654","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"6780_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2337\/dc15-2418","volume":"39","author":"CL Lu","year":"2016","unstructured":"Lu CL, Shen HN, Hu SC, Wang JD, Li CY (2016) A population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes. Diabetes Care 39(9):1571\u20131578. https:\/\/doi.org\/10.2337\/dc15-2418","journal-title":"Diabetes Care"},{"issue":"1","key":"6780_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/dc13-0701","volume":"37","author":"T Tsujimoto","year":"2014","unstructured":"Tsujimoto T, Yamamoto-Honda R, Kajio H et al (2014) Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37(1):217\u2013225. https:\/\/doi.org\/10.2337\/dc13-0701","journal-title":"Diabetes Care"},{"issue":"9","key":"6780_CR23","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1111\/dom.13348","volume":"20","author":"C Fitzpatrick","year":"2018","unstructured":"Fitzpatrick C, Chatterjee S, Seidu S et al (2018) Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab 20(9):2169\u20132178. https:\/\/doi.org\/10.1111\/dom.13348","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"6780_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/dom.16168","volume":"27","author":"K Alkhuzam","year":"2025","unstructured":"Alkhuzam K, Li P, Abuloha S et al (2025) Long-term health benefit and economic return of time in range (TIR) improvement in individuals with type 2 diabetes. Diabetes Obes Metab 27(3):1564\u20131571. https:\/\/doi.org\/10.1111\/dom.16168","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"6780_CR25","doi-asserted-by":"publisher","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","volume":"107","author":"M Yapanis","year":"2022","unstructured":"Yapanis M, James S, Craig ME et al (2022) Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J Clin Endocrinol Metab 107(6):e2221\u2013e2236. https:\/\/doi.org\/10.1210\/clinem\/dgac034","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"6780_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.eprac.2025.08.004","volume":"31","author":"KL Urbina","year":"2025","unstructured":"Urbina KL, Slyne C, Munshi MN (2025) Diabetes technology and the older adult: clinical outcomes and implementation strategies. Endocr Pract 31(12):1626\u20131631. https:\/\/doi.org\/10.1016\/j.eprac.2025.08.004","journal-title":"Endocr Pract"},{"key":"6780_CR27","unstructured":"Fujifilm Healthcare. ARIETTA 850 \u2013 Overview. Available at: https:\/\/www.fujifilm.com\/pl\/en\/healthcare\/ultrasound\/arietta\/arietta-850. Accessed 8 May 2026"},{"issue":"11","key":"6780_CR28","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/dc22-0470","volume":"45","author":"B Matejko","year":"2022","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B et al (2022) Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study. Diabetes Care 45(11):2628\u20132635. https:\/\/doi.org\/10.2337\/dc22-0470","journal-title":"Diabetes Care"},{"issue":"1","key":"6780_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ecl.2019.10.001","volume":"49","author":"E Toschi","year":"2020","unstructured":"Toschi E, Munshi MN (2020) Benefits and challenges of diabetes technology use in older adults. Endocrinol Metab Clin North Am 49(1):57\u201367. https:\/\/doi.org\/10.1016\/j.ecl.2019.10.001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"6780_CR30","doi-asserted-by":"publisher","first-page":"EVIDe2400389","DOI":"10.1056\/EVIDe2400389","volume":"4","author":"M Munshi","year":"2025","unstructured":"Munshi M, Toschi E (2025) Diabetes care for the aging population in the digital age. NEJM Evid 4(1):EVIDe2400389. https:\/\/doi.org\/10.1056\/EVIDe2400389","journal-title":"NEJM Evid"},{"issue":"3","key":"6780_CR31","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/S2666-7568(22)00005-8","volume":"3","author":"CK Boughton","year":"2022","unstructured":"Boughton CK, Hartnell S, Thabit H et al (2022) Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. Lancet Healthy Longev 3(3):e135\u2013e142. https:\/\/doi.org\/10.1016\/S2666-7568(22)00005-8","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"6780_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2021.0246","volume":"24","author":"M Munshi","year":"2022","unstructured":"Munshi M, Slyne C, Davis D et al (2022) Use of technology in older adults with type 1 diabetes: clinical characteristics and glycemic metrics. Diabetes Technol Ther 24(1):1\u20139. https:\/\/doi.org\/10.1089\/dia.2021.0246","journal-title":"Diabetes Technol Ther"},{"key":"6780_CR33","doi-asserted-by":"publisher","unstructured":"Pratley RE, Casu A (2022) Can technology improve the management of older adults with type 1 diabetes? Yes, but\u2026\u00a0Lancet Healthy Longev 3(3):e120-e121. https:\/\/doi.org\/10.1016\/s2666-7568(22)00032-0","DOI":"10.1016\/s2666-7568(22)00032-0"},{"key":"6780_CR34","doi-asserted-by":"publisher","first-page":"111962","DOI":"10.1016\/j.diabres.2024.111962","volume":"219","author":"R Franceschi","year":"2025","unstructured":"Franceschi R, Pertile R, Marigliano M et al (2025) Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents. Diabetes Res Clin Pract 219:111962. https:\/\/doi.org\/10.1016\/j.diabres.2024.111962","journal-title":"Diabetes Res Clin Pract"},{"key":"6780_CR35","doi-asserted-by":"publisher","first-page":"193229682513187","DOI":"10.1177\/19322968251318740","volume":"14","author":"KE Karakus","year":"2025","unstructured":"Karakus KE, Akturk HK, Snell-Bergeon JK, Shah VN (2025) Progression of diabetic retinopathy after initiation of automated insulin delivery system in adults with type 1 diabetes. J Diabetes Sci Technol 14:19322968251318740. https:\/\/doi.org\/10.1177\/19322968251318740","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"6780_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/dia.2024.0568","volume":"27","author":"MME Johansson","year":"2025","unstructured":"Johansson MME, March de Ribot F, Sime MJ et al (2025) Short-term diabetic retinopathy status in people with type 1 diabetes commencing automated insulin delivery. Diabetes Technol Ther 27(5):386\u2013394. https:\/\/doi.org\/10.1089\/dia.2024.0568","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"6780_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1089\/dia.2023.0038","volume":"25","author":"P Dekker","year":"2023","unstructured":"Dekker P, Aanstoot HJ, Sas T et al (2023) Prevalence of and reasons for discontinuation of continuous subcutaneous insulin infusion in people with type 1 diabetes: a systematic review. Diabetes Technol Ther 25(8):559\u2013570. https:\/\/doi.org\/10.1089\/dia.2023.0038","journal-title":"Diabetes Technol Ther"},{"key":"6780_CR38","doi-asserted-by":"publisher","unstructured":"Elhenawy Y, Thijs I, Siegelaar S et al (2025) Minimed\u2122 780G system provides equal performance in female users compared to males in all age groups from pre-puberty to menopause. Oral: 891. Diabetologia 68(Suppl 1):S1\u2013S754. https:\/\/doi.org\/10.1007\/s00125-025-06497-1","DOI":"10.1007\/s00125-025-06497-1"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06780-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:03:10Z","timestamp":1785481390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6780"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06780-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Parts of this study were presented in poster form and in a lecture at the 85th American Diabetes Association meeting [ADA 2025, Chicago;\n                      Diabetes\n                      2025; 74(Suppl 1): 948-P].","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Access to the data will be granted by the corresponding author upon reasonable request and subject to approval by the study sponsor and compliance with applicable ethical and legal requirements. Data sharing will be limited to requests for scientifically justified analyses that are consistent with the original study objectives. Each request will be evaluated on a case-by-case basis, and a data sharing agreement may be required prior to data transfer. The data will be available for up to 2 years following publication. Any shared data will be fully anonymised, and no identifying participant information will be disclosed.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"External Research Project grant from MiniMed International Trading Sarl (ERP 2022-13079): covering investigator costs, consumables and device loan.","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"BM has received speakers\u2019 honoraria from Abbott, Ascensia, Dexcom, Roche, Synoptis Pharma and Medtronic. KC has received speakers\u2019 honoraria from Abbott, Ascensia and Medtronic. PS and KS have received speakers\u2019 honoraria from Medtronic. TK has received speakers\u2019 honoraria from Eli Lilly, Sanofi, Novo Nordisk, Abbott, Roche, Medtronic, Boehringer Ingelheim, Bioton and Servier; served on an advisory panel for Eli Lilly, Sanofi, Boehringer Ingelheim, Ascensia and Abbott; and provided research support for Medtronic. MTM has received speakers\u2019 honoraria from Eli Lilly, Sanofi, Novo Nordisk, Ascensia, Abbott, Roche, Medtronic, Boehringer Ingelheim, Bioton and Servier; and served on an advisory panel for Eli Lilly, Sanofi, Boehringer Ingelheim, Ascensia and Abbott.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"BM, KC, PS, KS, JK, JC and TK researched data. BM, KC and TK wrote the manuscript. BM, KC, MTM, PM, PS, KS, JK, JC and TK contributed to the discussion and reviewed and edited the manuscript. All authors have improved the final version of the manuscript. TK is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}